Desk Report :: When it comes to coronavirus vaccines, the first question most people ask is – when will I get vaccinated? So far only a few countries have been able to set a specific goal of bringing most of their citizens under vaccination. The situation in the rest of the world is still unclear.
Coronavirus cannot be effectively controlled without vaccinating most people in the world. And that’s why, as scientific research as well as multilateral cooperation talks are going on, different countries are also active behind the scenes to get vaccinated earlier.
As a result, it is difficult to understand when it will be possible to bring everyone in the world under vaccination, according to a BBC analytical report.
The Economist Intelligence Unit led by its director Agatha DeMaris conducted a study on the subject.
The study looked at the world’s vaccine production capacity, the health sector’s ability to vaccinate, how many people have been vaccinated so far, and how much a country can afford to buy vaccines.
The results show that the difference between rich and poor countries has become clearer when it comes to vaccination.
If their predictions are correct, the United States, the United Kingdom and a few countries in Western Europe will be able to vaccinate everyone by 2021. Russia, Canada, most South American countries and Australia may reach that goal by mid-2022.
India, China and East Asian countries will be able to vaccinate most of the population by the end of 2022. Most countries in Bangladesh, Central Asia and Africa will have to wait until the first half of 2023.
The BBC writes that so far the United States and the United Kingdom have been able to ensure adequate supply of vaccines to their citizens because they have the ability to invest huge sums of money behind making vaccines. This is what has taken them to the forefront.
Canada and other rich countries in Europe that have not paid as much attention to vaccination are lagging slightly behind the United States and the United Kingdom.
Canada was criticized late last year for buying five times as many vaccines as the country needed. But as it turns out, they could not confirm the previous supply.
One of the reasons Canada is lagging behind is that it relies heavily on European factories for vaccines, the BBC writes. They feared that US President Donald Trump might ban vaccine exports. To avoid risk, they have entered into agreements with European companies instead of the United States.
But that bet did not benefit Canada, but rather increased the risk. European vaccine plants are not able to thrive. As a result, the European Union is now threatening to stop exports.
Agatha DeMaris said she felt that meeting European demand would not be as important as European countries until they were vaccinated enough.
Research by the Economist Intelligence Unit says most low-income countries have yet to start vaccinating their citizens. However, some countries have gone beyond expectations.
Serbia now ranks eighth in the world in terms of vaccination compared to the population; They have advanced in this direction more than any other country in Europe.
At the heart of Serbia’s success is being able to start vaccinating them efficiently, the BBC writes. They have also benefited from competition from Russia and China over the sale of vaccines in Eastern Europe. Serbia is one of the few countries where Russia’s Sputnik Veer as well as China’s Sinofarm are being vaccinated.
The form that Serbia has developed for vaccinating citizens has the opportunity to choose between Pfizer, Sputnik and Synoform. However, there is more interest in the Chinese vaccine.
Sinofarm is getting long-term benefits. In countries where they are being vaccinated in the first and second doses, they will also need to buy the next booster dose from Synoform.
The UAE is also relying heavily on synoform vaccines. Now 80 percent of the vaccines they are giving to citizens are from that Chinese company. A vaccine manufacturing center is also being set up at Cinopharma in the UAE.
Although China and India have become superpowers in the field of vaccination, it is also a big challenge for them to quickly get the majority of their population under vaccination.
If the Economist Intelligence Unit’s forecast is correct, China or India will not be able to finish vaccinating a sufficient number of their citizens before the end of 2022.
The big reason for this is the huge population of the two countries. More than 1.3 billion people live in the two countries, and there is a shortage of health workers.
The Seram Institute of India is playing a major role in India’s success as a vaccine producer. Last January, they started producing and supplying vaccines invented by Oxford-AstraZeneca. Now there are 24 lakh doses of vaccine being made every day.
The Serum Institute is providing vaccines not only to the Government of India, but also to Brazil, Morocco, Bangladesh and South Africa.
Adar Poonawala, CEO of the company, said, “After the start of vaccine production, I thought, now the feeling of stress and insanity for vaccines will decrease a bit. But now the big challenge is to keep everyone happy.
“I figured the other producers would be able to start supplying enough. But sadly, in this first quarter of the year, even in the second quarter, we may not see significant progress in providing vaccines around the world.
Source: Unitednews24.com by www.unitednews24.com.
*The article has been translated based on the content of Unitednews24.com by www.unitednews24.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!